Recent News

Posted by Burton on December 21st, 2012 in Headlines  ⟩  0 comments
Lee BioSolutions Supplies D-Dimer , Key Component of Deep Vein Thrombosis Detection and Pulminary Embolism to major diagnostic companies worldwide

ST. LOUIS , MO Lee BioSolutions, an international manufacturer, producer and supplier of high purity proteins and antigens announces an increased in supply of D-Dimer protein. The St. Louis-based biotechnology firm recently developed a proprietary process to effectively and efficiently purify the marker for Deep Vein Thrombosis and Pulmonary Embolism. As a result, Lee is supplying bulk quantities of this critical components for thrombosis tests to major manufacturers for early detection of blood clots to prevent DVT.

According to the Centers of Disease and Control, CDC, , Deep Vein Thrombosis and Pulmonary Embolism affects up to 600,000 individuals in the US alone each and every year . What happens in the most serious of cases is Deep Vein Thrombosis or DVT when part of a blood clot breaks off in the leg and travels through the bloodstream to the lungs causing a blockage called pulmonary embolism. DVT/PLE shows no preference to age, gender or ethnicity and is one of those disorders that is repeatedly underdiagnosed causing serious illness, disability and even death. In fact 10% of individuals diagnosed with DVT will die within the first month of diagnosis because they were not treated early enough. With risk factors such as aging population , more sedentary habits among individuals and obesity , this disorder is becoming an important and growing public health concern.

Lee’s new D-Dimer production capabilities enables international diagnostics companies to quickly manufacture serum D-Dimer tests, which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Lee Biosolutions is on the forefront of Coagulation disorders and Deep Vein Thrombosis research by supplying a highly purified clot dissolving substance call D-Dimer from human serum “ said Burton Lee, President of Lee Biosolutions . “ D-Dimer test is used for detecting increased D dimer in your blood is most useful for ruling out deep vein thrombosis or for identifying people at risk of recurrence. “

Lee Biosolutions is also involved with early detection of Diabetes with our new HbA1c and detection of Chronic Kidney Disease with cystatin C protein . We are all about saving lives with early detection of clinical diseases.

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity human, animal and recombinant proteins, biological fluids , antibodies and immunoreagents. Headquartered in St. Louis and founded in 1981, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include human neutrophil elastase, human myeloperoxidase isoform c, alpha fetoprotein, beta 2 microglobulin, and amylase. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit www.LeeBio.com or call 314-968-1091.
Posted by Burton on December 16th, 2012 in Headlines  ⟩  0 comments

Saint Louis, MO Lee Biosolutions Inc, is an international manufacturer, producer and supplier of high purity biomarkers used in the prediction, prevention and management of cardiovascular diseases known as CVD. The St. Louis-based biotechnology health care firm has developed a unique proprietary process to effectively and efficiently purify Biochemical Biomarkers such as Low Density Lipoprotein (LDL) and High Density Lipoprotein(HDL) from Human Plasma used by manufacturers of lipid profile blood tests. As a result, Lee is now is a preferred producer for clinical researchers and diagnostic companies around the world to supply these critical components .

According to the World Health Organization located in Switzerland, 30% of all global deaths are attributed to CVD which encompasses a group of disorders of the heart and blood vessel. These disorders include coronary heart disease, cerebrovascular disease, peripheral arterial disease , rheumatic heart disease, congenital heart disease and deep vein thrombosis and pulmonary embolism.
Lee’s cholesterol products, Low Density Lipoprotein and High Density Lipoproteins are carefully isolated from human plasma and are supplied to international diagnostic companies to produce quality diagnostic tests for Cholesterol ,HDL,LDL and Triglycerides. As a result, Lee has hired additional scientists to meet global market demand.

Burton Lee , President of Lee Biosolutions says, Cholesterol itself is not a problem but its when you have high levels of cholesterol and LDL is when you run into trouble. Too many people think of cholesterol as something bad but in actuality you need cholesterol for the synthesis of vitamin D and hormones in your body. Cholesterol is needed to help with fat absorption molecules by converting to bile in your digestive tract. One way to manage your health is to get a lipid profile test and that’s where we come in. We are the supplier of these analytes that go into these blood tests. We also see another promising set of biomarkers that will be very popular for heart disease management and they are Pro-BNP and NT-proBNP which we are offering . “

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity finished human proteins. Headquartered in St. Louis and founded in 2002, the biotechnology healthcare firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein(LDL),High Density Lipoprotein(HDL), CkMB and Troponin, Myeloperoxidase, C-Reactive Protein and NT-proBNP, The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit http://www.LeeBio.com or call 314-968-1091.

Posted by Burton on May 14th, 2012 in Headlines  ⟩  0 comments

Lee BioSolutions Inc, an international manufacturer and producer of high purity proteins and antigens announces the isolation and increased production of Acid Phosphatase and Prostate Specific Antigen. The St. Louis-based healthcare- biotechnology firm has developed a unique proprietary process to effectively and efficiently purify the prostate cancer Tumor Marker PSA and its isoforms. As a result, Lee is now is a preferred producer for researchers and diagnostic companies to supply these critical components .

According to the National Cancer Institute, there is an estimated 241,000 new cases of prostate cancer in the United States along and 28,000 men will not survive this year . There is over 2.5 million men who are currently living with the disease.

Lee’s Prostate Specific Antigen production capabilities enables international diagnostics companies to quickly manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand. PSA protein that is produced by Lee Biosolutions is used in diagnostic tests which help in the diagnosis, to assess the patiences response to treatment, and allows Docters to look for recurrence.

“Lee Biosolutions is on the forefront of Prostate Cancer research by supplying highly purified markers such as PSA and its isoforms . A PSA Test measures the level of PSA in the blood and is one of the tools used for screening men with prostate cancer. With continued improvements in screening, diagnosis and treatment of prostate cancer more men are living with the disease .” said Burton Lee, President of Lee Biosolutions.

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Alpha FetoProtein used in detection of liver cancer and germ cell tumors,Beta 2 Microglobulin used to detect multiple myeloma, chronic lymphocytic leukemia and some lyophomas, Thyroglobulin for detecting Thyroid Cancer, and Lactate Dehydrogenase used to assess state and prognosis of Germ cell tumors.    The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee Biosolutions visit http://www.LeeBio.com or call 314-968-1091.

Posted by Burton on March 15th, 2012 in Headlines  ⟩  0 comments
 

ST. LOUIS , MO  Lee Biosolutions Inc, an international manufacturer, producer and supplier of high purity finished proteins and antigens announces  increased production of  beta 2 MICROGLOBULIN .   The St. Louis-based  healthcare- biotechnology firm has  developed a unique  proprietary process to effectively and efficiently purify  B2M in bulk.  As a result, Lee is now is a preferred producer for researchers and  diagnostic companies to supply  this critical tumor marker for multiple myelomas and lymphomas.

Beta 2 MICROGLOBULIN is an important blood plasma protein used for detecting some blood cell cancers as lymphomas and multiple myelomas and for detecting kidney damage. B2M is used for prognosis because it is found on the surface of many cells, including lymphocytes, and in small amounts in the blood and urine. According to the CDC, there are over 10,000 deaths of multiple myeloma per year and over 20,000 people dying from lymphoma just in the United States alone. Lymphoma is the most common form of blood cancer in the developed world.

“ We feel that Lee Biosolutions is on the forefront of Blood Cell Cancer research  by supplying  highly purified  markers such as Beta 2 Microglobulin to the research community and clinical diagnostic market.  A B2M Test measures the level of B2M in the blood  or urine and is one of the tools used  for identifying disease activity and tumor burden.  With continued  improvements in screening, diagnosis and treatment of blood cancers and kidney damage  more individuals are able to manage their disease earlier and live longer .”  said Burton Lee, President of Lee Biosolutions.

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished   proteins.  Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes finished and intermediate proteins  used in drug discovery and development , clinical diagnosis and product testing. These include Alpha Feto Protein used in detection of liver cancer and germ cell tumors, Beta 2 Microglobulin used to detect multiple myeloma, chronic lymphocytic leukemia and some lyophomas,  THYROGLOBULIN for detecting Thyroid Cancer,   and Lactate Dehydrogenase used to assess state and prognosis of Germ cell tumors.    The company is ISO 9001:2008 certified, FDA registered and approved by APHIS for exporting . To learn more about Lee BioSolutions visit www.LeeBio.com or call 314-968-1091.
Posted by Burton on January 30th, 2012 in Headlines  ⟩  0 comments
Lee BioSolutions Inc, an international manufacturer, producer and supplier of high purity proteins and antigens announces that it will supply high purity Hemoglobin A1C to the Diabetes Market. Hemoglobin A1C is isolated from Red Blood cells and is used as an indicator of blood glucose in a diabetic patient. The A1C test is an important test in the diagnosis and management of diabetes.

According to the World Health Organization there are over 350 million people who have diabetes worldwide. Current news reports say that 50% of individuals living in the United States are either pre-diabetic or diabetic.

Lee Biosolutions recognizes the growing diabetes market and is committed in providing the highest quality Hemoglobin A1C protein and is working closely with major diagnostic companies to meet demand of this highly desirable indicator. . In addition to isolating A1C from red blood cells, Lee Biosolutions is also providing prediabetic, diabetic Type 1 and diabetic Type 2 urine from donors.

“Lee Biosolutions is on the forefront of Diabetes research by supplying highly purified markers such as Hemoglobin A1C,“ said Burton Lee, President of Lee Biosolutions . “ What is unique about this test is that patients do not need to fast as with the common fasting plasma glucose test. Since HbA1C builds up in red blood cells throughout the lifetime of diabetic patients, its levels represent an excellent record of blood glucose levels over the previous 2-3 months. We are happy to be a part of early diagnosis of a disease that is so common but is taken so much for granted.“

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished human proteins. Headquartered in St. Louis and founded in 2002, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein (LDL),High Denisity Lipoprotein(HDL), Myeloperoxidase, C-Reactive Protein, CkMB and Troponin, The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit http://www.LeeBio.com or call 314-968-1091.